Mather Group
PFE icon

Mather Group’s Pfizer PFE Stock Holding History

Mather Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$743K Sell
26,049
-5,567
-18% -$148K 0.01% 445
2026
Q2 		$761K Sell
31,616
-2,150
-6% -$56.2K 0.01% 440
2026
Q1 		$948K Buy
33,766
+10,994
+48% +$293K 0.01% 343
2025
Q4 		$567K Buy
22,772
+10,363
+84% +$261K 0.01% 384
2025
Q3 		$316K Buy
12,409
+741
+6% +$18.3K ﹤0.01% 504
2025
Q2 		$283K Sell
11,668
-10,517
-47% -$245K ﹤0.01% 516
2025
Q1 		$562K Buy
22,185
+1,978
+10% +$51.8K 0.01% 353
2024
Q4 		$536K Sell
20,207
-4,602
-19% -$125K 0.01% 346
2024
Q3 		$718K Sell
24,809
-25,734
-51% -$751K 0.01% 289
2024
Q2 		$1.4M Buy
50,543
+23,989
+90% +$660K 0.02% 220
2024
Q1 		$764K Sell
26,554
-1,179
-4% -$32.7K 0.01% 263
2023
Q4 		$798K Sell
27,733
-6,436
-19% -$195K 0.01% 261
2023
Q3 		$1.13M Buy
34,169
+8,857
+35% +$313K 0.02% 200
2023
Q2 		$928K Sell
25,312
-10,537
-29% -$410K 0.01% 243
2023
Q1 		$1.46M Sell
35,849
-16,274
-31% -$703K 0.03% 168
2022
Q4 		$2.67M Buy
52,123
+2,709
+5% +$130K 0.05% 120
2022
Q3 		$2.16M Buy
49,414
+7,601
+18% +$369K 0.05% 125
2022
Q2 		$2.19M Buy
41,813
+2,338
+6% +$119K 0.05% 120
2022
Q1 		$2.04M Buy
39,475
+17,910
+83% +$929K 0.04% 108
2021
Q4 		$1.27M Buy
21,565
+6,875
+47% +$341K 0.02% 130
2021
Q3 		$632K Sell
14,690
-386
-3% -$17.1K 0.02% 147
2021
Q2 		$590K Buy
15,076
+163
+1% +$6.34K 0.01% 146
2021
Q1 		$540K Sell
14,913
-677
-4% -$24K 0.02% 142
2020
Q4 		$574K Sell
15,590
-909
-6% -$33.3K 0.02% 126
2020
Q3 		$574K Sell
16,499
-1,076
-6% -$37.7K 0.02% 125
2020
Q2 		$545K Buy
+17,575
New +$597K 0.03% 125

Other funds holding PFE

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Artemis Investment Management
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
Fort Washington Investment Advisors
Fort Washington Investment Advisors Cincinnati, Ohio $19.7B AUM 20.11% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
MN Services Vermogensbeheer
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
Czech National Bank
Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Mather Group's PFE Position: Q3 2026 in Review

Mather Group reduced its Pfizer (PFE) stake by 18% in Q3 2026, selling an estimated $148K and leaving 26,049 shares worth $743K. The position accounts for 0.01% of the portfolio, ranked #445.

Mather Group first reported a position in PFE in Q2 2020 and has held it in 26 quarters since. The position peaked at $2.67M in Q4 2022. 822 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Mather Group held 26,049 shares of Pfizer worth $743K as of Q3 2026.
  • Mather Group sold 5,567 Pfizer shares in Q3 2026, an estimated $148K.
  • Pfizer made up 0.01% of Mather Group's portfolio in Q3 2026, its #445 holding.
  • Mather Group first reported a position in Pfizer in Q2 2020 and has held it in 26 quarters since.
  • Mather Group's Pfizer position peaked at $2.67M in Q4 2022.
  • 822 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.